Your browser doesn't support javascript.
loading
The Herbal Formula CWBSD Improves Sleep Quality Dependent on Oral Microbial Type and Tongue Diagnostic Features in Insomnia.
Kim, Min-Jee; Bose, Shambhunath; Shin, Na-Rae; Park, Seohyun; Kwon, Ojin; Song, Eun-Ji; Nam, Young-Do; Koo, Byung-Soo; Nam, Dong-Hyun; Lee, Jun-Hwan; Kim, Hojun.
Affiliation
  • Kim MJ; Department of Rehabilitation Medicine of Korean Medicine, Dongguk University, Goyang 10326, Korea.
  • Bose S; Department of Rehabilitation Medicine of Korean Medicine, Dongguk University, Goyang 10326, Korea.
  • Shin NR; Department of Rehabilitation Medicine of Korean Medicine, Dongguk University, Goyang 10326, Korea.
  • Park S; Department of Rehabilitation Medicine of Korean Medicine, Dongguk University, Goyang 10326, Korea.
  • Kwon O; Division of Clinical Medicine, Korea Institute of Oriental Medicine, Daejeon 34054, Korea.
  • Song EJ; Research Group of Healthcare, Korea Food Research Institute, Wanju-gun 55365, Korea.
  • Nam YD; Department of Food Biotechnology, Korea University of Science and Technology, Daejeon 34113, Korea.
  • Koo BS; Research Group of Healthcare, Korea Food Research Institute, Wanju-gun 55365, Korea.
  • Nam DH; Department of Food Biotechnology, Korea University of Science and Technology, Daejeon 34113, Korea.
  • Lee JH; Department of Korean Neuropsychiatry, Dongguk University, Goyang 410-773, Korea.
  • Kim H; Department of Biofunctional Medicine and Diagnosis, College of Korean Medicine, Sangji University, Wonju 26382, Korea.
J Pers Med ; 11(5)2021 Apr 21.
Article in En | MEDLINE | ID: mdl-33919176
Cheonwangbosim-dan (CWBSD) is a traditional Korean herb formula that has been widely prescribed for insomnia patients with a heart-yin deficiency (HYD) pattern. Several studies have reported that heart function and insomnia are interrelated, and few have explored associations between insomnia, oral microbiota, and tongue diagnosis. This study aimed to evaluate the effects of CWBSD on primary insomnia, tongue diagnosis, and oral microbiota. At baseline, 56 patients with primary insomnia were assigned to two groups, a HYD group and a non-HYD (NHYD) group and they took CWBSD for 6 weeks. During the study, Pittsburgh Sleep Quality Indices (PSQIs) and Insomnia Severity Indices (ISIs) decreased significantly in both groups. However, the PSQI reduction observed in the HYD group was greater than in the NHYD group and sleep times increased only in the HYD group. As sleep quality improved, the amount of tongue coating increased at the posterior tongue, where heart function appears. At baseline, the HYD and NHYD group had a specific oral microbiota (Veillonella at genus level), but no significant change was observed after taking CWBSD. Additionally, subjects were divided into two oral microbiota types ("orotypes"). The genera Prevotella, Veillonella, or Neisseria were abundant in each orotype. The reduction in PSQI in orotype 1 during the 6-week treatment period was greater than in orotype 2. In conclusion, this study shows that CWBSD could be used to treat primary insomnia in patients with a HYD pattern as determined using tongue diagnosis and oral microbiota distributional patterns.
Key words

Full text: 1 Database: MEDLINE Type of study: Diagnostic_studies Language: En Year: 2021 Type: Article

Full text: 1 Database: MEDLINE Type of study: Diagnostic_studies Language: En Year: 2021 Type: Article